Small (Sendai Negative) Branch-Duct IPMNs
- 1 August 2012
- journal article
- research article
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 256 (2) , 313-320
Abstract
Objective: The aim of this study was to evaluate existing management guidelines for branch-duct intraductal papillary mucinous neoplasms (IPMNs). Background: According to current treatment guidelines (Sendai criteria), patients with asymptomatic branch-duct type IPMNs of the pancreas less than 3 cm in diameter without suspicious features in preoperative imaging should undergo conservative treatment with yearly follow-up examinations. Nevertheless, the risk of harboring malignancy or invasive cancer remains a significant matter of consequence. Methods: All patients who were surgically resected for branch-duct IPMNs between January 2004 and July 2010 at the University Clinic of Heidelberg were analyzed. Clinical characteristics of the patients and preoperative imaging were examined with regard to the size of the lesions, presence of mural nodules, thickening of the wall, dilation of the main pancreatic duct, and tumor markers. Results were correlated with histopathological features and were discussed with regard to the literature. Results: Among a total of 287 consecutively resected IPMNs, 123 branch-duct IPMNs were identified analyzing preoperative imaging. Some 69 branch-duct IPMNs were less than 3 cm in size, without mural nodules, thickening of the wall, or other features characteristic for malignancy (“Sendai negative”). Of all the Sendai negative branch-duct IPMNs, 24.6% (17/69) showed malignant features (invasive carcinoma or carcinoma in situ) upon histological examination of the surgical specimen. Conclusions: Although many branch-duct IPMNs are small and asymptomatic, they harbor a significant risk of malignancy. We believe that both main-duct and branch-duct IPMNs represent premalignant lesions. This should be taken into account for adequate therapeutic management. With regard to these results, the current Sendai criteria for branch-duct IPMNs need to be adjusted.Keywords
This publication has 24 references indexed in Scilit:
- Endoscopic ultrasound may be unnecessary in the preoperative evaluation of intraductal papillary mucinous neoplasmHPB, 2011
- Development of pancreatic cancers during long-term follow-up of side-branch intraductal papillary mucinous neoplasmsEndoscopy, 2010
- Current Trends in Pancreatic Cystic NeoplasmsArchives of Surgery, 2009
- Management of Mucin-Producing Cystic Neoplasms of the PancreasThe Oncologist, 2009
- Risk of Malignancy in Resected Cystic Tumors of the Pancreas ≤3 cm in Size: Is it Safe to Observe Asymptomatic Patients? A Multi-institutional ReportJournal of Gastrointestinal Surgery, 2007
- Natural history of branch duct intraductal papillary-mucinous neoplasms of the pancreas without mural nodules: long-term follow-up resultsGut, 2007
- International Consensus Guidelines for Management of Intraductal Papillary Mucinous Neoplasms and Mucinous Cystic Neoplasms of the PancreasPancreatology, 2006
- Natural History of Intraductal Papillary Mucinous Tumors of the Pancreas: Actuarial Risk of MalignancyClinical Gastroenterology and Hepatology, 2006
- Endoscopic ultrasound and computer tomography are inaccurate methods of classifying cystic pancreatic lesionsDigestive and Liver Disease, 2006
- An Illustrated Consensus on the Classification of Pancreatic Intraepithelial Neoplasia and Intraductal Papillary Mucinous NeoplasmsAmerican Journal of Surgical Pathology, 2004